ReviewCardiovascular diabetology2021

Hypofibrinolysis in type 2 diabetes and its clinical implications: from mechanisms to pharmacological modulation.

Agata Hanna Bryk-Wiązania et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.